Member Info for Soupdragon78

The required tests are non-GLP and GLP tests for toxicology.

Non-GLP is 4-6 weeks, run a few times to demonstrate repeatability.

Then GLP tests which are similar timeframe and open up the move into phase 1.

As the company says, you don’t necessarily need these to sign an outlicense deal (AstraZeneca deal with RedX was pre-GLP testing)

Littlened, its a positive, it shows you've bought below mid-price.

BP… Jeito are not involved.

Regular punters trades are always ‘off-book’ unless you have direct market access (DMA)

Don't know why that double posted

Transhaven, knowing what I do, Dan has certainly not been using NFX as a 'lifestyle' company, you don't get to where they are at without effort and perseverance, furthermore you don't get people like Phil Molyneaux and Andy Richards involved if your just taking out and not progressing.

Try submitting and obtaining EU ODD and FDA just for a lifestyle.... see how far you get.

Transhaven, knowing what I do, Dan has certainly not been using NFX as a 'lifestyle' company, you don't get to where they are at without effort and perseverance, furthermore you don't get people like Phil Molyneaux and Andy Richards involved if your just taking out and not progressing.

Try obtaining EU ODD and FDA ODD just for the lifestyle, see how far you get....

Have you written to Points of View as well?

Lol... its more the context of such disputative discourse being on here that is worthless.

Borges quote about the Falklands War seems quite apt at this moment.

The company need to move the process forward toward tox studies prior to phase 1 clinical. This will involve non-GLP studies first of all which will take circa 7-14 days per test, done a number of times to ensure repeatability.

These are relatively cheap and quick to do and open up a move to GLP toxicology studies which are a requirement before moving into Phase 1 clinical testing on humans.

A potential partner may or may not wait for the non-GLP and GLP studies to be done first before putting pen to paper. The closest comparison to one who did would be AstraZeneca signing a $17m deal with RedX in 2020 prior to non-GLP studies.

Zen, all you need to do is fact check before you post.

As is the fashion... I'm an honest, optimistic poster.... I just don't like b/s as it hurts the company profile.

Zen if you paid attention to what you post you’d see it’s full of mistakes.

Transhaven...

'.....But there is not anything going on here.'

I do not agree with this statement.

Posting drivel from a crypto exchange is not a positive.

Trans, Tonto replied to your thread. Things are happening.

DRF.

Soup.

Pulmocide…. lol… now where have we heard that name before.

They're in the room.

4 RNS' in March, two good ones and two compliance ones. Hardly quiet.

Think CMC are still offloading placing shares .